LORANGER STEVEN R 4
4 · Edwards Lifesciences Corp · Filed Feb 14, 2025
Insider Transaction Report
Form 4
LORANGER STEVEN R
Director
Transactions
- Sale
Common Stock
2025-02-14$76.42/sh−5,739$438,576→ 60,372 total - Exercise/Conversion
Director Stock Option (Right to Acquire)
2025-02-14−5,739→ 0 totalExercise: $45.32From: 2018-05-18Exp: 2025-05-17→ Common Stock (5,739 underlying) - Exercise/Conversion
Common Stock
2025-02-14$45.32/sh+5,739$260,073→ 66,111 total
Holdings
- 15,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $76.400 to $76.435. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.